skip to main content
Idioma:
Refinado por: Base de dados/Biblioteca: HEAL-Link subscriptions: Lippincott Williams & Wilkins remover assunto: Kidney Neoplasms - Drug Therapy remover Journal Of Clinical Oncology remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Salvage Ipilimumab and Nivolumab in Patients With Metastatic Renal Cell Carcinoma After Prior Immune Checkpoint Inhibitors
Salvage Ipilimumab and Nivolumab in Patients With Metastatic Renal Cell Carcinoma After Prior Immune Checkpoint Inhibitors
Material Type:
Artigo 		Adicionar ao Meu Espaço

Salvage Ipilimumab and Nivolumab in Patients With Metastatic Renal Cell Carcinoma After Prior Immune Checkpoint Inhibitors

Gul, Anita ; Stewart, Tyler F ; Mantia, Charlene M ; Shah, Neil J ; Gatof, Emily Stern ; Long, Ying ; Allman, Kimberly D ; Ornstein, Moshe C ; Hammers, Hans J ; McDermott, David F ; Atkins, Michael B ; Hurwitz, Michael ; Rini, Brian I

Journal of clinical oncology, 2020-09, Vol.38 (27), p.3088-3094 [Periódico revisado por pares]

United States: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
2
Phase II Study of Two Weeks on, One Week off Sunitinib Scheduling in Patients With Metastatic Renal Cell Carcinoma
Phase II Study of Two Weeks on, One Week off Sunitinib Scheduling in Patients With Metastatic Renal Cell Carcinoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase II Study of Two Weeks on, One Week off Sunitinib Scheduling in Patients With Metastatic Renal Cell Carcinoma

Jonasch, Eric ; Slack, Rebecca S ; Geynisman, Daniel M ; Hasanov, Elshad ; Milowsky, Matthew I ; Rathmell, W Kimryn ; Stovall, Summer ; Juarez, Donna ; Gilchrist, Troy R ; Pruitt, Lisa ; Ornstein, Moshe C ; Plimack, Elizabeth R ; Tannir, Nizar M ; Rini, Brian I

Journal of clinical oncology, 2018-06, Vol.36 (16), p.1588-1593 [Periódico revisado por pares]

United States: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
3
A Phase II Study of Intermittent Sunitinib in Previously Untreated Patients With Metastatic Renal Cell Carcinoma
A Phase II Study of Intermittent Sunitinib in Previously Untreated Patients With Metastatic Renal Cell Carcinoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

A Phase II Study of Intermittent Sunitinib in Previously Untreated Patients With Metastatic Renal Cell Carcinoma

Ornstein, Moshe C ; Wood, Laura S ; Elson, Paul ; Allman, Kimberly D ; Beach, Jennifer ; Martin, Allison ; Zanick, Beth R ; Grivas, Petros ; Gilligan, Tim ; Garcia, Jorge A ; Rini, Brian I

Journal of clinical oncology, 2017-06, Vol.35 (16), p.1764-1769 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.